GB 1886.165-2015
\u4e2d\u534e\u4eba\u6c11\u5171\u548c\u56fd\u536b\u751f\u90e8\u516c\u544a2011\u5e74\u7b2c8\u53f7-40-2011
\u4e2d\u534e\u4eba\u6c11\u5171\u548c\u56fd\u536b\u751f\u90e8\u516c\u544a2011\u5e74\u7b2c8\u53f7-41-2011
HG/T 5471\uff5e5473-2018
T/CDIA 0014-2020
T/QGCML 748-2023
T/ZZB 3053-2023
BS 7969:2004
Adhesives. Ethyl and methyl cyanoacrylate types 1,2 and 3
32008H0098
HG/T 5484\uff5e5487-2018
BS 3985:2003
Haemiglobincyanide (cyanmethaemoglobin) preparation as a standard for spectrometric haemoglobinometry
USP f100681
(Z)-3-Hexenyl 2-Methylbutyrate
USP f100699
5-Methyl 2-Phenyl 2-Hexenal
USP f101375
5-Methyl-2-isopropyl-2-hexenal
32018R1262
Commission Implementing Regulation (EU) 2018/1262 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, dimethenamid-p, diuron, fludioxonil, flufenacet, flurtamone, fosthiazate, indoxacarb, MCPA, MCPB, prosulfocarb, thiophanate-methyl and
32017R1511
Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid-p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate-methyl and tribenur
32015R1885
Commission Implementing Regulation (EU) 2015/1885 of 20 October 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-D, acibenzolar-s-methyl, amitrole, bentazone, cyhalofop butyl, diquat, esfenvalerate, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), glyphosate, iprovalicarb, isoproturon, lambda-cyhalothrin, metalaxyl-M, metsulfuron methyl, picolinafen
32017R1511R(01)
32013R0533
32008L0017
Commission Directive 2008/17/EC of 19 February 2008 amending certain Annexes to Council Directives 86/362/EEC, 86/363/EEC and 90/642/EEC as regards maximum residue levels for acephate, acetamiprid, acibenzolar-S-methyl, aldrin, benalaxyl, benomyl, carbendazim, chlormequat, chlorothalonil, chlorpyrifos, clofentezine, cyfluthrin, cypermethrin, cyromazine, dieldrin, dimethoate, dithiocarbamates, esfenvalerate, famoxadone, fenhexamid, fenitrothion, f